Tu1198: THE COMBINATION OF FGFR4 INHIBITOR H3B-5627 AND OXALIPLATIN PROMOTES DNA DAMAGE, CELL DEATH AND REDUCES TUMOR GROWTH IN VITRO AND IN PATIENT-DERIVED XENOGRAFT GASTRIC CANCER MODELS

Journal article

Peer reviewed

Mohammed Soutto, Nadeem Bhat, Ahmed El-Rifai, Marwah M. AL-Mathkour, Mohammed Chwihne, Oliver G. McDonald and Wael El-Rifai

Gastroenterology (New York, N.Y. 1943), Vol.169(1), p.S-1350

2025-05

Metrics

1 Record Views

Title: Tu1198: THE COMBINATION OF FGFR4 INHIBITOR H3B-5627 AND OXALIPLATIN PROMOTES DNA DAMAGE, CELL DEATH AND REDUCES TUMOR GROWTH IN VITRO AND IN PATIENT-DERIVED XENOGRAFT GASTRIC CANCER MODELS
Creators: Mohammed Soutto
Nadeem Bhat
Ahmed El-Rifai
Marwah M. AL-Mathkour
Mohammed Chwihne
Oliver G. McDonald
Wael El-Rifai
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.169(1), p.S-1350
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Department of Pathology; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032724971702976